Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 9 hours ago
Executive Interviews at Fierce Biotech Week 2026
about 9 hours ago
Discover how these trailblazers are accelerating breakthroughs, forging impactful partnerships, and redefining...
Could engaging the immune system improve AML outcomes?
about 10 hours ago
With unmet need still high in AML, new approaches are exploring whether...
How AI is reshaping biopharma decision-making
about 10 hours ago
AI is accelerating discovery, but only when paired with expert insight and...
Affibody gets izokibep ‘back on track’ while seeking ‘new home’ after drug’s Acelyrin rejection
about 11 hours ago
Affibody may not have expected to be working on izokibep again, but...
Insulet debuts latest enhancements to popular Omnipod insulin delivery system
about 11 hours ago
Insulet, the diabetes device maker, debuted upgrades to its popular Omnipod 5...
Chutes & Ladders—AstraZeneca adds FDA cell and gene veteran
about 13 hours ago
Longtime FDA leader Lola Fashoyin-Aje, M.D., is adapting to a new role...
How RA Capital is offering its biotechs ‘Chinese clinical expertise in a box’
about 13 hours ago
Rather than leave the work of developing relationships in China to individual...
At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts
about 16 hours ago
On Thursday, the public had the first chance to air their grievances...
Why City of Hope Built a National Clinical Trials Platform Designed to Scale With Oncology Innovation
1 day ago
City of Hope built a national trials engine to move oncology innovation...
Autobahn races toward pivotal trial after thyroid hormone mimic eases bipolar depression in ph. 2
1 day ago
A stimulator of thyroid hormone receptors in the brain has successfully reduced...
As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
1 day ago
Two federal lawmakers have introduced a bill seeking to apply the review...
Parabilis preps $413M IPO to fuel desmoid tumor drug into phase 3
1 day ago
Parabilis Medicines is gearing up for an IPO that could eventually bring...